These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24859379)

  • 1. Interactions of anticancer drugs with biomembranes: what can we learn from model membranes?
    Bourgaux C; Couvreur P
    J Control Release; 2014 Sep; 190():127-38. PubMed ID: 24859379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions with lipid membranes.
    Seddon AM; Casey D; Law RV; Gee A; Templer RH; Ces O
    Chem Soc Rev; 2009 Sep; 38(9):2509-19. PubMed ID: 19690732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How proteins move lipids and lipids move proteins.
    Sprong H; van der Sluijs P; van Meer G
    Nat Rev Mol Cell Biol; 2001 Jul; 2(7):504-13. PubMed ID: 11433364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity.
    Pawagi AB; Wang J; Silverman M; Reithmeier RA; Deber CM
    J Mol Biol; 1994 Jan; 235(2):554-64. PubMed ID: 7904655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model membrane platforms to study protein-membrane interactions.
    Sezgin E; Schwille P
    Mol Membr Biol; 2012 Aug; 29(5):144-54. PubMed ID: 22831167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-lipid therapy: a new approach in molecular medicine.
    Escribá PV
    Trends Mol Med; 2006 Jan; 12(1):34-43. PubMed ID: 16325472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of multidrug resistance in relation to passive membrane permeation.
    Eytan GD
    Biomed Pharmacother; 2005 Apr; 59(3):90-7. PubMed ID: 15795101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation--part II: diffusion and permeation of model drugs.
    Ochalek M; Podhaisky H; Ruettinger HH; Wohlrab J; Neubert RH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):360-6. PubMed ID: 22750439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models of lipid-protein interactions in membranes.
    Mouritsen OG; Bloom M
    Annu Rev Biophys Biomol Struct; 1993; 22():145-71. PubMed ID: 8347987
    [No Abstract]   [Full Text] [Related]  

  • 11. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
    Petersen ES; Kelley EE; Modest EJ; Burns CP
    Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD; Sharom FJ
    Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curvature-driven lipid sorting in biomembranes.
    Callan-Jones A; Sorre B; Bassereau P
    Cold Spring Harb Perspect Biol; 2011 Feb; 3(2):. PubMed ID: 21421916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein and lipid sorting from the trans-Golgi network to the plasma membrane in polarized cells.
    Ikonen E; Simons K
    Semin Cell Dev Biol; 1998 Oct; 9(5):503-9. PubMed ID: 9835637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysics in cancer: The relevance of drug-membrane interaction studies.
    Alves AC; Ribeiro D; Nunes C; Reis S
    Biochim Biophys Acta; 2016 Sep; 1858(9):2231-2244. PubMed ID: 27368477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy drugs form ion pores in membranes due to physical interactions with lipids.
    Ashrafuzzaman M; Tseng CY; Duszyk M; Tuszynski JA
    Chem Biol Drug Des; 2012 Dec; 80(6):992-1002. PubMed ID: 23006796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative dynamics of quasi-1D lipid structures and lateral transport in biological membranes.
    Kadantsev VN; Tverdislov VA; Yakovenko LV; Kadantsev VV
    Gen Physiol Biophys; 1997 Dec; 16(4):311-9. PubMed ID: 9595300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outlook on organization of lipids in membranes: searching for a realistic connection with the organization of biological membranes.
    Bagatolli LA; Ipsen JH; Simonsen AC; Mouritsen OG
    Prog Lipid Res; 2010 Oct; 49(4):378-89. PubMed ID: 20478336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.